AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
GENFIT reported Q1 2025 revenue of €2.8m, up from €1.1m in Q1 2024, driven by royalties from Ipsen on Iqirvo sales. The company's cash position increased to €129.5m at the end of March 2025, largely due to a royalty financing agreement with HCRx, which extended GENFIT's cash runway beyond 2027.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet